WebHá 1 dia · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... Web1y Target Est: N/A: Fair Value is the appropriate price for the shares of a company, ... CA / ACCESSWIRE / June 8, 2024 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology …
Oncology Pharma Stock Forecast: down to 0.000001 …
Web15 de out. de 2024 · Aerovate Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $24.67. Aerovate Therapeutics Inc next reports earnings on November 14. -CureVac BV ( CVAC) stock is trading at $39.94, a decline of $5.53, or 12.76%, on … WebSo, if you have transcribed the formula correctly, the calculation given the numbers in your example would be: 0.35 * 4 * 20 = $28.00. As to CVRR, I'm not sure your PE is correct. According to Yahoo, the PE for CVRR is 3.92 at the time of writing, not 10.54. Using the formula above, this would lead to: 2.3 * 4 * 3.92 = $36.06. city with u
Oncology Pharma Target Price Projection ONPH - Macroaxis
Web17 de mar. de 2024 · Get the latest Price and Consensus Chart for Oncology Pharma from Zacks Investment Research ONPH: Oncology Pharma - Price & Consenus Chart - … WebFind the latest ONCOLOGY PHARMA INC ONPH analyst stock forecast, price target, ... ONPH Oncology Pharma Inc. 0.4000-0.0150 (-3.62%) As of 07:38PM . Market open. … WebOncology Pharma entered into a Licensing Agreement with NanoSmart®Pharmaceuticals Inc. for its "novel" drug delivery platform that can target many types of cancer and other diseases. One of the keys to NanoSmart's® platform technology is a “patented”(US 7,799,327 and EU 1706145 B1) human-derived, antinuclear antibody (ANA) that targets … dough evolution blox fruits